RAGE and Its Ligands in Melanoma

April 2015 in “ InTech eBooks ”

Estelle Leclerc

RAGE receptor for advanced glycation end products S100 proteins S100B S100A2 S100A4 S100A6 p53 Advanced Glycation End-products AGEs High Mobility Group Box 1 protein HMGB1 soluble RAGE sRAGE anti-RAGE antibodies

Studysummary RAGE is a potential target for melanoma treatment, but its effectiveness is uncertain due to variable expression levels.

Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer

View this study on intechopen.com →

Discuss this study in the Community →

Research cited in this study

2 / 2 results

research RAGE and Its Ligands in Melanoma

1 citations , April 2015 in “InTech eBooks”

RAGE is a potential target for melanoma treatment, but its effectiveness is uncertain due to variable expression levels.

Expression of Calcium-Binding S100 Proteins A4 and A6 in Regions of the Epithelial Sac Associated with the Onset of Hair Follicle Regeneration

research Expression of Calcium-Binding S100 Proteins A4 and A6 in Regions of the Epithelial Sac Associated with the Onset of Hair Follicle Regeneration

72 citations , June 2001 in “Journal of Investigative Dermatology”

This study suggests that S100A4 and S100A6 proteins may play key roles in activating stem cells for hair follicle regeneration in mice.